Changes in misonidazole binding with hypoxic fraction in mouse tumors

Area of Science:

• Oncology
• Radiotherapy
• Biomedical Imaging

Background:

• Misonidazole (MISO) binding to hypoxic tumor cells aids in tumor identification and hypoxia assessment.
• Tumor hypoxia and radiobiological resistance can be modulated by altering host hematocrit.

Purpose of the Study:

• To investigate how acute changes in host hematocrit affect 14C MISO binding in tumors.
• To determine the relationship between MISO binding and tumor cell survival under varying hypoxia levels.

Main Methods:

• Tumor-bearing mice were made acutely anemic via transfusion.
• Mice received 14C MISO, were irradiated, and tumors were excised.
• Tumor halves were used for in vitro cell survival assays and 14C scintillation counting.

Main Results:

• Acutely anemic mice showed significantly increased tumor cell survival and 14C MISO binding.
• A linear log-log relationship existed between clonogenic cell survival and MISO binding across tumor lines.
• The slopes of this relationship varied by tumor line and were steeper than expected for a direct 1:1 correlation.

Conclusions:

• Acute anemia increases both tumor radioresistance and MISO binding.
• MISO binding serves as an indicator of radiobiological resistance in tumors.
• Non-clonogenic cells within tumors contribute to MISO binding, influencing the observed correlation with cell survival.